Expression of p73 gene, cell proliferation and apoptosis in breast cancer: Immunohistochemical and clinicopathological study

Oncology Reports

Volumn 9, Issue 4, 2002, Pages 729-735

  Yamamoto, Tatsuyoshi ^a   Oda, Koji ^a   Kubota, Tomoyuki ^a   Miyazaki, Kou ^a   Takenouti, Yasushi ^a   Nimura, Yuji ^a   Hamaguchi, Michinari ^a   Matsuda, Satoru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Breast cancer; Immunohistochemistry; p53; p73; Prognostic factors

Indexed keywords

DNA BINDING PROTEIN; KI 67 ANTIGEN; NUCLEAR PROTEIN; PRIMER DNA; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ADENOCARCINOMA; ADULT; APOPTOSIS; ARTICLE; BREAST; BREAST TUMOR; CASE CONTROL STUDY; CELL DIVISION; CHEMISTRY; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; LYMPH NODE METASTASIS; MASTECTOMY; METABOLISM; METASTASIS; MIDDLE AGED; MITOSIS INDEX; PATHOLOGY; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; APOPTOSIS; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL DIVISION; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; MITOTIC INDEX; NUCLEAR PROTEINS; PRECIPITIN TESTS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0036635916     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.4.729     Document Type: Article

References (23)

1. Lowe SW, Ruley HE, Jacks T and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993. (Pubitemid 23289454)
2. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810, 1994. (Pubitemid 24359290)
3. Fujiwara T, Grimm EA, Mukhopadhyay T, Zhang WW, Owen-Schaub LB and Roth JA: Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene. Cancer Res 54: 2287-2291, 1994. (Pubitemid 24138709)
4. Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S and Koga H: Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene 5: 1603-1610, 1990.
5. Elledge RM and Allred DC: Prognostic and predictive value of p53 and p21 in breast cancer. Breast Cancer Res Treat 52: 79-98, 1998. (Pubitemid 29056087)
6. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T and Kaelin WG Jr: A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 25: 47-54, 2000. (Pubitemid 30257035)
7. Murphy KL, Dennis AP and Rosen JM: A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model. FASEB J 14: 2291-2302, 2000.
8. Zaika AI, Kovalev S, Marchenko ND and Moll UM: Overexpression of the wild-type p73 gene in breast cancer tissues and cell lines. Cancer Res 59: 3257-3263, 1999. (Pubitemid 29316031)
9. Shishikura T, Ichimiya S, Ozaki T, Nimura Y, Kageyama H, Nakamura Y, Sakiyama S, Miyauchi M, Yamamoto N, Suzuki M, Nakajima N and Nakagawara A: Mutational analysis of the p73 gene in human breast cancers. Int J Cancer 84: 321-325, 1999. (Pubitemid 29256762)
10. Schwartz DI, Lindor NM, Walsh-Vockley C, Roche PC, Mai M, Smith DI, Liu W and Couch FJ: p73 mutations are not detected in sporadic and hereditary breast cancer. Breast Cancer Res Treat 58: 25-29, 1999. (Pubitemid 30003868)
11. Jost CA, Marin MC and Kaelin WG Jr: p73 is a simian (correction of human) p53-related protein that can induce apoptosis. Nature 389: 191-194, 1997. (Pubitemid 27400602)
12. Yokomizo A, Mai M, Tindall DJ, Cheng L, Bostwick DG, Naito S, Smith DI and Liu W: Overexpression of the wild-type p73 gene in human bladder cancer. Oncogene 18: 1629-1633, 1999. (Pubitemid 29108063)
13. Yamamoto T, Oda K, Miyazaki K, Ichigotani Y, Takenouchi Y, Kamei T, Shirafuji N, Nimura Y, Hamaguchi M and Matsuda S: p73 is highly expressed in myoepithelial cells and in carcinomas with metaplasia. Int J Oncol 19: 271-276, 2001.
14. Van Diest PJ, Baak JP, Matze-Cok P, Wisse-Brekelmans EC, van Galen CM, Kurver PH, Bellot SM, Fijnheer J, van Gorp LH and Kwee WS: Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23: 603-607, 1992.
15. Lehr HA, Hansen DA, Kussick S, Li M, Hwang H, Krummenauer F, Trouet S and Gown AM: Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count. Hum Pathol 30: 1314-1320, 1999. (Pubitemid 29534293)
16. Bottini A, Berruti A, Bersiga A, Brizzi MP, Brunelli A, Gorzegno G, Di Marco B, Aguggini S, Bolsi G, Cirillo F, Filippini L, Betri E, Bertoli G, Alquati P and Dogliotti L: p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. Clin Cancer Res 6: 2751-2758, 2000. (Pubitemid 30482114)
17. Davis PK and Dowdy SF: p73. Int J Biochem Cell Biol 33: 935-939, 2001.
18. Krause K, Haugwitz U, Wasner M, Wiedmann M, Mossner J and Engeland K: Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumor suppressor protein p53 but not by p73. Biochem Biophys Res Commun 284: 743-750, 2001. (Pubitemid 32924792)
19. Zhu J, Nozell S, Wang J, Jiang J, Zhou W and Chen X: p73 cooperates with DNA damage agents to induce apoptosis in MCF7 cells in a p53-dependent manner. Oncogene 20: 4050-4057, 2001. (Pubitemid 32681610)
20. Dominguez G, Silva J, Silva JM, Garcia JM, Miralles C, Rodriguez O, Jareno E, Provencio M, Espana P and Bonilla F: Clinicopathological characteristics of breast carcinomas with allelic loss in the p73 region. Breast Cancer Res Treat 63: 17-22, 2000.
21. Ahomadegbe JC, Tourpin S, Kaghad M, Zelek L, Vayssade M, Mathieu MC, Rochard F, Spielmann M, Tursz T, Caput D, Riou G and Benard J: Loss of heterozygosity, allele silencing and decreased expression of p73 gene in breast cancers: prevalence of alterations in inflammatory breast cancers. Oncogene 19: 5413-5418, 2000.
22. Corn PG, Kuerbitz SJ, van Noesel MM, Esteller M, Compitello N, Baylin SB and Herman JG: Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res 59: 3352-3356, 1999. (Pubitemid 29334490)
23. Kawano S, Miller CW, Gombart AF, Bartram CR, Matsuo Y, Asou H, Sakashita A, Said J, Tatsumi E and Koeffler HP: Loss of p73 gene expression in leukemias/lymphomas due to hypermethylation. Blood 94: 1113-1120, 1999. (Pubitemid 29361845)